Solve M.E.’s 2026 State of the Union: From Protecting Progress to Building What’s Next
In our 2026 State of the ME/CFS Union Address, Solve M.E. leadership shared a vision
October 21, 2026
In our 2026 State of the ME/CFS Union Address, Solve M.E. leadership shared a vision
On October 20th at 1 pm PT / 4 pm ET, Solve M.E. is bringing our
Could IVO-21 Lead to a New ME/CFS Mitochondrial Treatment? In May 2026, Solve selected Dr.
In honor of Severe ME/CFS Awareness Month, our friends at Bateman Horne Center recently hosted
Dr. Avik Roy is the chief scientific officer at the Simmaron Research Institute, a nonprofit
In recognition of World ME Day, Solve M.E. announced today new funding for two award-winning
Dr. Liisa Selin, Dr. Ayano Kohlgruber, and Dr. Roshan Kumar received a Solve ME/CFS Catalyst
Glucagon-Like Peptide-1 (GLP-1) agonist medications, like semaglutide, are injectable or oral drugs that mimic the
In our “What’s New in ME/CFS?” series, we spotlight researchers transforming what we can do
Solve M.E. is proud to support two pioneering studies through our latest round of ME/CFS
In our What’s New in ME/CFS? series, we spotlight researchers transforming what we know –
Caring for someone with ME/CFS is an act of deep love–and preparation is one of
